<DOC>
	<DOCNO>NCT00224146</DOCNO>
	<brief_summary>This study evaluate change health relate quality life outcome patient use Oxytrol ( r )</brief_summary>
	<brief_title>Transdermal ( TDS ) Oxybutynin ( Oxytrol ( r ) ) Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Adult patient one symptom overactive bladder , include urge urinary incontinence , urgency and/or frequency Patients Oxytrol ( r ) contraindicate . Patients treat Oxytrol ( r ) prior participation study . Patients reside longterm care facility nurse home .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Oxytrol ( r )</keyword>
	<keyword>transdermal oxybutynin</keyword>
	<keyword>overactive bladder</keyword>
</DOC>